Fig. 5

IPF patients with high ATII-CCL20 proportion in integrated data had a worse prognosis. A GSE27957, GSE28042, and GSE70866 data integration and batch effect removal were performed for the subsequent analysis. B The difference in OS between IPF patients with high and low ATII-CCL20 proportion in the integrated data. C, D GO enrichment analysis and KEGG pathway enrichment analysis of DEGs between IPF patients with high and low ATII-CCL20 proportion in the integrated data. E Box plots showed the different GSVA scores of hallmark pathways in IPF patients with high and low ATII-CCL20 proportion, *p < 0.05, **p < 0.01, ***p < 0.001. F Univariate Cox analysis revealed the correlation between the GSVA score of hallmark pathways and OS in IPF patients. G A Venn diagram showed 17 hallmark pathways that were useful for risk stratification of IPF patients based on ATII-CCL20 proportion